The interleukin 2-diphtheria toxin-related fusion protein (IL-2-toxin) rapidly inhibits protein synthesis in IL-2 receptor (IL-2R)-bearing phytohemagglutinin-activated T cells but transiently stimulates DNA synthesis. At 7 hr after interaction with IL-2R+ phytohemagglutinin-activated T cells, IL-2-toxin-treated cells bear augmented steady-state levels of c-myc, interferon y, and IL-2R mRNA; these effects are indistinguishable from those produced by recombinant IL-2. Amplification of IL-2 sequences by the polymerase chain reaction reveals an increased level of IL-2 mRNA in cell cultures treated with recombinant IL-2, IL-2-toxin, and cycloheximide. These results suggest that IL-2-toxin can affect de novo IL-2 gene transcription/mRNA stabilization through independent mechanisms exerted by both the IL-2R binding domain and ADP-ribosyltransferase activity of the fusion protein. After 20 hr of culture, IL-2R mRNA was markedly decreased in both IL-2-toxin-and cycloheximide-treated phytohemagglutinin-activated T cells. Although interaction of IL-2-toxin with IL-2R+ T cells initially mimics the stimulatory effects of IL-2 upon c-myc, interferon y, IL-2R, and IL-2 gene expression, the consequences of inhibition of protein synthesis mediated by the ADP-ribosyltransferase activity of the toxin dominate after 7 hr and are indistinguishable from those effects mediated by cycloheximide.A fusion gene encoding the interleukin 2-diphtheria toxin fusion protein (IL-2-toxin) was constructed from a truncated diphtheria toxin gene by replacing DNA sequences coding for the toxin receptor binding domain with sequences coding for amino acids 2-133 of human IL-2 (1). The mature form of IL-2-toxin has a deduced molecular mass of 68 kDa, and the fusion protein retains at least some functional attributes of both its diphtheria toxin and IL-2 components. The fusion protein (i) binds with high affinity to the multimeric IL-2 receptor (IL-2R), (ii) is internalized by IL-2R-mediated endocytosis, and (iii) mediates the ADP-ribosylation of elongation factor 2 in the target-cell cytosol (2).Binding of IL-2 to its high-affinity receptor rapidly activates intracellular processes that lead to gene activation and de novo gene transcription, DNA synthesis, and cell cycle progression (3)(4)(5)(6). Even though IL-2-toxin rapidly inhibits protein synthesis in IL-2R-bearing phytohemagglutinin (PHA)-activated T cells, we now note that this chimeric toxin also transiently stimulates DNA synthesis (e.g., thymidine incorporation).In the present study we demonstrate that binding of the IL-2-toxin to the high-affinity IL-2R initially produces effects in the PHA-activated target cell that are indistinguishable from those mediated by IL-2 itself. Subsequently, the fusion protein inhibits cellular protein synthesis. Additional indirect effects of IL-2-toxin upon T-cell gene activation, produced by the inhibition of protein synthesis, are characterized herein.
MATERIALS AND METHODSCell Cultures. Human peripheral blood mononuclear cells were isolated by means...